Jul 1, 2026 08:05AM
Jul 1, 2026 08:05AM
Jun 16, 2026 04:02PM
Jun 16, 2026 04:01PM
May 21, 2026 05:36PM
May 21, 2026 05:17PM
May 12, 2026 07:02AM Rigel licenses VEPPANU breast cancer drug for $85 million upfront
May 12, 2026 07:00AM
May 5, 2026 04:01PM
Mar 31, 2026 08:07AM
Mar 31, 2026 08:05AM
Mar 3, 2026 04:01PM
Jan 12, 2026 08:07AM
Jan 12, 2026 08:05AM Rigel Provides Business Update and 2026 Outlook
Dec 7, 2025 09:30AM
Dec 7, 2025 09:30AM
Nov 17, 2025 08:05AM
Nov 17, 2025 08:05AM
Nov 4, 2025 04:01PM
Nov 3, 2025 09:05AM
Oct 9, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Rigel Pharmaceuticals (RIGL)
Oct 8, 2025 08:05AM
Oct 8, 2025 08:05AM
Aug 5, 2025 04:01PM
May 22, 2025 05:21PM
May 22, 2025 05:20PM
May 6, 2025 04:01PM
Mar 27, 2025 08:05AM Rigel Pharma (RIGL) Announces Settlement Agreement Resolving TAVALISSE Patent Litigation
Mar 27, 2025 08:05AM
Mar 10, 2025 08:07AM
Mar 10, 2025 08:05AM
Mar 5, 2025 06:51AM
Mar 4, 2025 04:01PM
Jan 22, 2025 08:05AM
Jan 22, 2025 08:05AM Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease
Jan 13, 2025 08:05AM
Jan 13, 2025 08:05AM
Jan 9, 2025 08:05AM
Dec 9, 2024 12:02PM
Dec 9, 2024 12:02PM
Dec 2, 2024 08:05AM
Dec 2, 2024 08:05AM Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Nov 7, 2024 04:01PM
Nov 5, 2024 09:05AM
Oct 24, 2024 04:36PM
Oct 24, 2024 04:35PM
Oct 16, 2024 10:01AM
Oct 16, 2024 10:00AM
Sep 5, 2024 07:30AM Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasidenib) in mIDH1 AML
Sep 3, 2024 08:03AM

324,757 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All